by Pete Celano | Oct 19, 2026 | Blog
Fatty liver disease can follow very different paths—and someone’s weight or diabetes status may not reveal how serious their liver risk is. That is the main message of this study from Mayo Clinic and Virginia Tech. Researchers analyzed medical records and genetic...
by Brandon Tudor | Oct 17, 2026 | Blog
The 10/14/2026 article titled “Recompensation may represent a new treatment-related state in cirrhosis” was published by the American Association for the Advancement of Science (AAAS).Recompensation means that someone whose cirrhosis caused serious...
by David Sires | Oct 15, 2026 | Blog
We just read the article titled “GLP-1-based treatments and long-term clinical outcomes in MASLD amongst older adults: a retrospective cohort study” from the 09/21/2026 edition of Age & Aging. GLP-1 medicines were linked to fewer serious liver...
by Brandon Tudor | Oct 13, 2026 | Blog
The main message from the article “Cardiovascular Complications of Chronic Liver Disease” is that liver disease can threaten your heart as well as your liver—and that connection is often overlooked. This article reviews existing research rather than...
by Pete Celano | Oct 10, 2026 | Blog, Press
Liver disease access in the USA? Months-out, in person. LiverRight makes it same-week, telemedicine. Refer to our clinic in all 50 states, and we’ll deliver on liver for YOUR patients. We take most insurances and offer cash-pay options for adults across all...
by David Sires | Oct 8, 2026 | Blog
In his October 7, 2026 Forbes article, “The Next Big Health Crisis May Be Hiding in Your Liver,” Dr. Peter Ubel highlights the growing public health threat of metabolic dysfunction–associated steatotic liver disease (MASLD), commonly known as fatty liver disease....
